Revascularization for controlling hypertension and improving cardiorenal failure in Leriche syndrome.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2022
Historique:
revised: 15 05 2022
received: 31 03 2022
accepted: 27 06 2022
pubmed: 10 7 2022
medline: 6 12 2022
entrez: 9 7 2022
Statut: ppublish

Résumé

Leriche syndrome usually occurs when atherosclerotic obstructions result in luminal narrowing of the abdominal aorta or iliac arteries and leads to thrombosis; it rarely causes heart or renal failure. We report the case of a 58-year-old Asian man with heart and renal failure as the dominant clinical manifestations of renovascular hypertension caused by Leriche syndrome. We performed an aorto-bifemoral bypass and unilateral renal artery stenting. Post-operative echocardiography showed improved cardiac function, with the left ventricular ejection fraction increasing from 30% before surgery to 54.2% after surgery. Moreover, his heart rate and blood pressure became stable, and his serum creatinine and brain natriuretic peptide levels decreased from 3.46 to 1.08 mg/dL and 685 to 4 pg/mL, respectively. Our case report shows that aorto-bifemoral bypass and unilateral renal artery stenting can effectively treat heart and renal failure resulting from renovascular hypertension caused by Leriche syndrome.

Identifiants

pubmed: 35808953
doi: 10.1002/ehf2.14069
pmc: PMC9715786
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

3608-3613

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Natl Med Assoc. 1985 Jan;77(1):57, 61
pubmed: 3968717
ESC Heart Fail. 2022 Oct;9(5):3608-3613
pubmed: 35808953
Angiology. 2002 May-Jun;53(3):349-52
pubmed: 12025924
ESC Heart Fail. 2020 Oct;7(5):3184-3188
pubmed: 32558325
J Gen Intern Med. 2010 Oct;25(10):1102-4
pubmed: 20568019
Can J Cardiol. 2008 Jul;24(7):568
pubmed: 18612499
Ann Surg. 1948 Feb;127(2):193-206
pubmed: 17859070
N Engl J Med. 2014 Jan 2;370(1):13-22
pubmed: 24245566
Cardiovasc Interv Ther. 2016 Jul;31(3):171-82
pubmed: 27052017
Arch Surg. 1963 Aug;87:230-8
pubmed: 14042673
ESC Heart Fail. 2019 Apr;6(2):319-327
pubmed: 30614643

Auteurs

Sho Takagi (S)

Department of Cardiovascular Surgery, Toyohashi Heart Center, Toyohashi, Japan.

Keisuke Hirano (K)

Department of Cardiology, Toyohashi Heart Center, Toyohashi, Japan.

Akio Nakasu (A)

Department of Cardiovascular Surgery, Toyohashi Heart Center, Toyohashi, Japan.

Junji Yanagisawa (J)

Department of Cardiovascular Surgery, Toyohashi Heart Center, Toyohashi, Japan.

Yoshihiro Goto (Y)

Department of Cardiovascular Surgery, Toyohashi Heart Center, Toyohashi, Japan.

Yasuhide Okawa (Y)

Department of Cardiovascular Surgery, Toyohashi Heart Center, Toyohashi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH